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Abstract
A strong relationship exists between increased inflammatory cytokines and muscle insulin resistance in obesity. This study
focused on identifying a relationship between metabolic propensity and myostatin expression in muscle and spleen cells in
response to high-fat diet intake. Using a comparative approach, we analyzed the effects of high-fat diet intake on myostatin
and follistatin expression, spleen cell composition, and potential cytokine expression in high-fat diet induced obesity
(HFDIO) resistant (SWR/J) and susceptible (C57BL/6) mice models. Results demonstrated overall increased myostatin
expression in muscle following high-fat diet intake in HFDIO-susceptible mice, while myostatin expression levels decreased
initially in muscle from high-fat diet fed resistant mice. In HFDIO-resistant mice, myostatin expression decreased in spleen,
while myostatin increased in spleen tissue from HFDIO-susceptible mice. Proinflammatory cytokine (IL-17, IL-1b, and IFNc)
potential increased in splenocytes from HFDIO-susceptible mice. In comparison, C57BL/6 mice fed a high-fat diet exhibited
higher frequencies of CD4
+/CD44
hi and CD8
+/CD44
hi cells in the spleen compared to control fed mice. Together, these
results suggest that susceptibility to high-fat diet induced obesity could be influenced by local myostatin activity in a tissue-
specific manner and that splenocytes exhibit differential cytokine production in a strain-dependent manner. This study sets
the stage for future investigations into the interactions between growth, inflammation, and metabolism.
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Introduction
The pathophysiology of obesity and type 2 diabetes is complex
and is associated with environmental and lifestyle risk factors that
include a sedentary lifestyle and an overweight condition. The
onset of type 2 diabetes can, in most cases, be reversed with
lifestyle changes including diet and exercise. However, the
mechanisms controlling this pathophysiology are unclear. Gluco-
and lipitoxicity are considered to play key roles in the development
of type 2 diabetes [1,2], with the primary molecular defect being
impaired insulin-stimulated glucose transport and decreased
glycogen synthesis in skeletal muscle [3]. Skeletal muscle
represents the most important tissue for maintenance of balanced
glucose homeostasis since it accounts for ,80% of insulin-
stimulated glucose uptake [4]. Muscle is also the predominant
tissue for whole body lipid oxidation, with up to 90% of the energy
requirements at rest being derived from fatty acids [5].
Recently, Zhao et al. [6] demonstrated that disrupting
myostatin (MSTN) function by overexpressing its propeptide
protects against dietary-induced obesity and insulin resistance.
MSTN is a myokine known to negatively regulate muscle growth
and impact body fat accumulation. Myostatin is produced as a
375-amino acid propeptide that is proteolytically cleaved at the
RSRR (263) site to produce the 26-kDa active MSTN [7]. The
resulting prodomain has been shown to inhibit the negative
growth activity of active MSTN [8]. Myostatin-null mice show a
two-fold increase in muscle mass compared to wild-type mice, as
well as a significant suppression of body fat accumulation [9,10].
Similarly, transgenic mice expressing muscle-specific MSTN
propeptide exhibit 20% faster growth and 44% more muscle
mass than wild-type controls, but maintain normal adipose tissue
[6]. In addition, follistatin has been shown to bind and inhibit
MSTN activity [11,12]. Conversely, overexpression of the active
MSTN peptide in muscle results in low muscle weights and
increased fat mass [13], suggesting that processing of MSTN may
play a role in energy partitioning between protein and fat,
counteracting muscle-wasting disorders that are prevalent in many
disease states including diabetes.
A strong link exists between increased inflammatory cytokines,
such as tumor necrosis factor-alpha (TNF-a) and interleukin-6 (IL-
6), and insulin resistance in obese individuals [14]. In response to
high fat intake, a low-grade systemic inflammatory response is seen
along with increased intramyocellular adipose deposition. A
previous study demonstrated that age, intramyocellular lipid,
and TNF-a are the strongest predictors of insulin resistance [15].
However, the mechanisms regulating the interactions between the
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fully elucidated. It has been known for some time that high-fat
diets can generally compromise protective immune responses
[16,17]. Recently, the dysfunction of the innate immune response
to influenza and increased mortality was linked directly to obesity
[18]. It is still unclear where the regulation interactions lie between
metabolic and immune response regulation. The intent of the
current study was to evaluate the interactions between high-fat diet
intake, MSTN expression, and spleen cell population dynamics in
two strains of mice exhibiting differential responses to dietary
intake. To the authors’ knowledge, this is the first report of
differential MSTN expression in different strains of mice, as well as
the first report of MSTN expression in spleen and leukocytes in
mice.
Materials and Methods
Ethics Statement
Institutional Animal Care and Use Committees at both
University of Wisconsin-Milwaukee and North Dakota State
University approved all animal procedures.
Animals and Experimental Design
Six week old mice, SWR/J and C57BL/6 strains, were used for
these experiments (Jackson Laboratories, Bar Harbor, ME).
C57BL/6 mice exhibit a high susceptibility to diet-induced obesity,
type 2 diabetes, and atherosclerosis [19,20]. High-fat, high-simple-
carbohydrate, low-fiber diet produces obesity in C57BL/6J mice as
well as fasting blood glucose levels of greater than 240 mg/dl and
blood insulin levels of greater than 150 microU/ml [20], suggesting
that the C57BL/6J mouse carries a genetic predisposition to
develop non-insulin-dependent (type 2) diabetes. The SWR/J
mouse is resistant to diet-induced obesity and does not exhibit
glucose intolerance associated with obesity [21]. Mice were allowed
to acclimate for a period of two weeks to the facilities, which were
maintained at constant 20uC and 50% humidity with a 12:12 hour
light:dark cycle. Mice were acclimated to the control diets for two
weeks. Each strain of mouse was divided equally into two
experimental groups, which included 1) Control: fed a control diet
(10% kcal fat, Research Diets Inc., D12450B), or 2) High-fat: fed a
high-fatdiet(60%kcalfat,Research DietsInc.,D12492).Micewere
fed experimental diets for 12 wk ad libitum, and given free access to
water. Each treatment group of mice was divided and housed in
sub-groups and each experiment was repeated (n=3/grp, n=6
total). Individual body weight, whole blood glucose, and average
daily food intake were measured weekly. All mice were fasted for
12 h prior to any biological sampling and were euthanized by CO2
inhalation prior to end-point sampling (cardiac puncture bleed and
tissue collections).
Sample Collection and Analysis
Tissue and blood samples were collected at end-point sampling
for further analyses. Spleen and skeletal muscle (pool of
gastrocnemius and soleus) samples were collected and immediately
placed on dry ice until further processing. Blood was collected
from live animals via the saphenous vein (50 ml) or terminal
cardiac puncture (500 ml) for analysis for blood glucose using an
Accu-chek Blood Glucose Meter (Roche Diagnostics). Spleen
samples isolated at the 6-wk sampling period were used for either
RNA isolation (n=6) or for ex vivo lymphocyte activation (n=4).
Lymphocyte Activation
T lymphocyte stimulation and activation was performed on
individual spleens isolated from SWR and C57BL/6 mice fed
either a high-fat or control diet for 6 weeks using modifications to
the methods described by Trickett and Kwam [22]. Spleen
samples (n=4) were homogenized by glass dounce homogenizers
in Hank’s buffered saline to result in a single cell suspension.
Following removal of red blood cells and granulocytes using a
Percol density gradient, mononuclear leukocytes were suspended
in RPMI 1640 medium supplemented with 1% L-glutamine, 1%
Hepes, 1% sodium pyruvate, 1% penicillin and streptomycin, and
0.1% beta-mercaptoethanol (complete RPMI, cRPMI). Single cell
suspensions were incubated with DynaBeads (CD3/CD28 beads,
Invitrogen) to expand and activate T lymphocytes. No difference
in total cell counts was detected between treatment groups
following cell separation. Cells were plated in cRPMI at a density
of 1610
6/mL and cultured at 37uC, 10% CO2. Aliquots of cell
supernatants (100 mL) were collected at 48, 72, and 96 h.
Supernatants were spun at 3,0006g for 10 minutes, flash frozen
and stored at 280uC until assayed for cytokine production.
Cellular Composition of Spleen Tissues
Spleens were harvested from all groups of mice into RPMI 1640
supplemented with 10% fetal bovine serum (FBS) and 1%
penicillin and streptomycin. Spleens were forced through a mesh
screen to obtain a single cell suspension. Red blood cells were
removed using RBC Lysis Buffer following manufacturer’s
directions (eBioscience). Following two washes with supplemented
RPMI, splenocytes were counted and aliquots of 1610
6 cells were
made for each staining combination as well as for flow cytometry
compensation controls. Staining was done in labeling buffer (PBS
plus 5% FBS). Antibodies used for staining were: FITC anti-mouse
CD4, PE-Cy5 anti-mouse CD8, FITC anti-mouse CD19, PE anti-
mouse CD44, PE anti-mouse CD25, PE anti-mouse CD69. Cells
were stained for 30 minutes at 4uC in the dark. Following one
wash in labeling buffer, samples were fixed using Cytofix Solution
according to manufacturer’s directions (BD), resuspended in
300 ml labeling buffer, and data were collected on a FACSCalibur
(BD). Data were analyzed using FlowJo (Treestar).
Quantitative Real-Time PCR
Changes in genetic expression of myostatin (MSTN), follistatin
(FSTN), and interleukin-6 (IL-6) in muscle and spleen samples were
evaluated by real-time reverse transcription quantitative PCR
(RT-qPCR). Total RNA samples were reverse transcribed using
SuperScript II RNase H
- reverse transcriptase (Invitrogen) and
oligo dT primers to obtain first-strand cDNA. First-strand cDNAs
were diluted 1:20 and used as templates for qPCR analysis.
Reactions (25 ml total volume) containing 1 ml diluted template,
150 nM each primer, and 1X Platinum SYBR Green qPCR
SuperMix (Invitrogen) were run in triplicate using the Mx3000P
real-time PCR system (Stratagene) and the following cycling
parameters: 50uC for 5 min; 95uC for 2 min; 40 cycles of 95uC for
15 s, 52uC for 15 s, 72uC for 30 s. No-template controls were run
for all primer pairs and PCR efficiencies were calculated for each
primer pair. Mean cycle threshold values (Ct values) for each
target gene were normalized with mean beta-actin Ct values.
Primer PCR efficiencies were calculated and utilized for PCR
correction for all primer pairs and normalized data were analyzed
using the standard curve quantification method [23].
Myostatin Protein Production Analysis
Total muscle and spleen MSTN protein levels were detected
using Western ligand blot techniques. Total tissue proteins (10 mg)
were separated on reducing SDS-PAGE gels (8–16% Tris-HCl,
Pierce) and transferred to nitrocellulose membranes (ProTran,
0.45 mm). Myostatin prodomain immunoreactive peptides (MPIPs)
Myostatin and Inflammation
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1539, R&D Systems). Putative pro-myostatin (,50 kDa) and
prodomain (,37 kDa) were detected in muscle, while putative
processed prodomain (,32 and 35 kDa) and further processed
immunoreactive peptides (,15 kDa) were detected in spleen tissue.
Cytokine Expression Analysis
Cytokine expression was evaluated in cultured, activated spleen
lymphocyte populations utilizing a commercially available protein
array that recognizes 12 inflammation-related cytokines, including
granulocyte macrophage-colony stimulating factor (GM-CSF),
interferon-c (IFNc), IL-1a, IL-1b, IL-2, IL-4, IL-5, IL-6, IL-10,
IL-12, IL-17, and TNFa. The ExcelArray
TM Mouse Inflammation
Array (82005, ThermoFisher) was utilized to detect the expression
of cytokines by activated splenic lymphocytes isolated from high
fat fed and control animals of both strains of mice. The array is a
multiplex fluorescent sandwich ELISA that contains internal
normalization, standards for quantification, and is optimized for
cell culture supernatants. The assay was performed according to
the recommendations of the manufacturer. Briefly, neat cell
culture supernatants were incubated on the slides for 2 h, and a
streptavidin detection system was utilized to visualize. Visualiza-
tion was conducted two ways to ensure accuracy of detection.
Slides were sent to the manufacturer for slide reading and data
acquisition, while other slides were scanned, analyzed, and data
acquired using the GenePix Array Scanner and software. No
differences were detected between data sets utilizing the two
scanning techniques.
Statistical Analysis
All RT-qPCR data were analyzed using the standard curve
method where cycle threshold values were compared to standard
curves generated and validated for each primer pair to result in a
relative starting copy number of mRNA. All comparisons within
strains were analyzed by two-way analysis of variance (ANOVA)
with factors being time and treatment using GraphPad Prism
version 5.0c for Mac OS X, GraphPad Software, San Diego
California USA, www.graphpad.com. Bonferroni post-hoc com-
parisons were conducted when overall interactions were significant
(P,0.05) to test for differences between treatment groups at each
sampling time.
All cytokine, weight, and blood glucose data were analyzed
using three-way analysis of variance (StatPlus, AnalystSoft) with
factors being strain, time, and treatment. Pairwise multiple-
comparison tests were conducted by the Holm-Sidak or Tukey-
Kramer method to compare between and within strains only when
main effects were significant. Cell frequencies were analyzed using
two-way analysis of variance with factors being strain and time.
Pairwise comparisons were conducted as previously stated.
Normality of sample distribution was tested by Normal Quantile
Plot (Q-Q Plot), and residuals were plotted against predicted
values to evaluate dependency between the means and variances
and test the assumption of homogeneity of variances. Results were
reported as least square means 6 SE.
Results
SWR mice are resistant to high-fat diet induced obesity
Over the 12-wk feeding trial, C57BL/6 mice fed the high-fat
diet consistently gained weight, while the other treatment groups
failed to exhibit significant weight gain (Fig. 1a). Significant weight
increases were detected as early as 3 weeks on the high-fat diet in
C57BL/6 mice. At 12 wk, the high-fat fed C57BL/6 mice nearly
doubled their weight from wk 1, 43.0360.10 g vs. 24.2560.08 g.
No difference was detected between the control- and high-fat fed
SWR mice throughout the trial. In addition, there was no
difference between SWR mice (control or high-fat) and the control
C57BL/6 group at any time point in the feeding trial.
Consistent with weight changes between the experimental
groups, the C57BL/6 high-fat fed group exhibited increased blood
glucose levels at 3, 6, 9, and 12 wk following dietary intake
(Fig. 1b). Overall, blood glucose levels were elevated 2.45-fold in
C57BL/6 mice fed the high-fat diet compared to mice fed the
control diet (236650 mg/dl compared to 96610 mg/dl). How-
ever, SWR mice fed a high-fat diet did not exhibit elevated blood
glucose levels compared to control group (9467 mg/dl vs.
81614 mg/dl). These levels were significantly lower than the
C57BL/6 high-fat group, but not different from the C57BL/6
mice fed the control diet. In addition, there was no difference
detected in voluntary feed intake between any group of mice
throughout the feeding trial (data not shown).
High-fat diet induced obesity results in differential
molecular regulation of growth-related genes in muscle
and spleen tissue
No difference was detected in IL-6 mRNA levels in muscle or
spleen of C57BL/6 or SWR mice fed a high-fat diet. In addition,
Figure 1. SWR/J mice are resistant to HFDIO. Body weight (a) and
whole blood glucose (b) in C57BL/6 and SWR/J mice strains fed
experimental diets for 12 wk. Control diet =10% kcal fat, high-fat diet
=60% kcal fat.
doi:10.1371/journal.pone.0012928.g001
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C57BL/6 or SWR control fed mice in either tissue. In contrast,
MSTN mRNA levels were increased by high-fat diet intake in
muscle tissue of SWR and C57BL/6 mice after 9 and 12 wk,
respectively (Fig. 2a and 2c). At 3 wk, MSTN mRNA levels were
decreased in SWR muscle while levels increased in C57BL/6
muscle. Levels of MSTN mRNA were higher at 3 and 6 wk, and
lower at 12 wk, in muscle from control SWR mice compared to
control C57BL/6 mice. SWR spleen MSTN mRNA levels
decreased at 6 wk and 9 wk on the high-fat diet (Fig. 2d).
C57BL/6 spleen MSTN levels increased 8.8460.13-fold at 3 wk
on the high-fat diet, with no change detected at 6, 9, or 12 wk
(Fig. 2b). MSTN mRNA levels in spleen of SWR mice fed the high-
fat diet were consistently lower than control fed mice, regardless of
strain. No difference was detected in MSTN mRNA levels between
C57BL/6 or SWR control mice. The presence of myostatin in
whole spleen and isolated leukocytes was confirmed through
traditional RT-PCR (Fig. 2e).
Follistatin levels were similar to MSTN levels in muscle tissue of
C57BL/6 mice, with an increase (Fig. 3a) at 3, 9, and 12 wk.
However, FSTN mRNA levels in muscle of high-fat fed SWR
mice were lower than control fed levels at 9 wk (Fig. 3c). Control
FSTN levels were higher in SWR muscle than C57BL/6 muscle
only at the 9 wk sampling period. In C57BL/6 mice, FSTN
mRNA levels in spleen increased following 3 wk feeding of high-
fat diet compared to control fed animals (92.5068.36 compared
to 16.3462.35 copies, respectively; Fig. 3b). Similarly in SWR
high-fat fed mice, spleen FSTN mRNA levels increased
compared to control fed levels (1084646.56 compared to
434.6618.67), but not until 9 wk on the diet (Fig. 3d). Control
spleen levels of FSTN mRNA were higher in SWR mice at both 6
and 9 wk.
Figure 2. Myostatin is attenuated in spleens of HFDIO-resistant mice fed high fat. Molecular regulation of myostatin (MSTN) mRNA levels
using quantitative real-time PCR. Myostatin mRNA levels in muscle from C57BL/6 (a) and SWR/J (c) and spleen from C57BL/6 (b) and SWR/J (d). Muscle
and spleen samples were taken at 3, 6, 9, and 12 wk on the dietary treatment. (e) RT-PCR analysis of myostatin mRNA expression in different tissues
for verification. Mar) 100 bp ladder, Spl) whole spleen, Leu) isolated leukocytes (CD3/CD28), mus) pooled skeletal muscle, Adi) adipose tissue, and ntc)
no template control. * demonstrates between dietary treatment differences at a given time, P,0.05.
doi:10.1371/journal.pone.0012928.g002
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mice than resistant mice
Myostatin prodomain immunoreactive peptides were detected in
both muscle and spleen tissue from C57BL/6 and SWR mice
(Fig. 4a, b). Myostatin immunoreactive peptides of ,50 and
37 kDa, consistent with precursor MSTN and MSTN prodomain
respectively, were detected in muscle tissue from both C57BL/6
and SWR mice (Fig. 4a). No differences were detected in MSTN
prodomain expression levels between strains, diets, or over time on
the diets (Fig. 4c). Precursor MSTN expression levels were higher in
muscle from C57BL/6 mice compared to SWR regardless of diet
(Fig. 4c). Myostatin immunoreactive peptides of ,32 and 16 kDa,
consistent with processed MSTN prodomain and potentially further
processed MSTN prodomain respectively, were detected in spleen
tissue protein from both C57BL/6 and SWR mice (Fig. 4b). Two
MSTN immunoreactive peptides were detected between 30 and
33 kDa. Both MPIPs (32 and 31 kDa) were expressed at higher
levels in C57BL/6 spleen than in SWR spleen regardless of
treatment (Fig. 4d). No differences were detected between strains or
as an effect of diet on the 16 kDa MPIP.
Cytokine production potential is affected by both high-
fat diet intake and strain
IL-4 expression by activated CD3/CD28 splenic T cells
isolated from SWR mice was consistently decreased in high-fat
fed mice compared to control (e.g., low-fat fed) mice at all
sampling times (Fig. 5a). Similarly, IL-2 levels were decreased in
SWR mice on the high-fat diet compared to the control diet at all
time points after lymphocyte activation (Fig. 5b). In C57BL/6
mice, the high-fat dietary treatment resulted in an increase in IL-2
levels by spleen cells at 48 h T cell activation with levels almost
twice as high as those in control mice. IL-2 levels were consistently
higher in the high-fat fed C57BL/6 group compared to the low-
fat fed group, with levels below the detection limit in the latter
group at 72 and 96 h. This is in direct contrast to SWR mice, with
consistently lower IL-2 levels expressed by high-fat fed mice than
controls. IL-5 levels were elevated in the high-fat fed SWR group
compared to control fed mice (Fig. 5c). In contrast, both IL-4 and
IL-5 levels were below the detection limit in spleen cell
supernatants from C57BL/6 mice at all sampling times and
treatments groups.
Interferon-c (IFNc) levels were consistently higher in C57BL/6
mice, regardless of dietary treatment, compared to SWR mice,
with the exception of the high-fat fed SWR group at 48 h after
activation (Fig. 6a). IL-17 levels were elevated in C57BL/6 high-
fat fed mice compared to controls at all time points (Fig. 6b). In
comparison, IL-17 levels were undetectable at 48 h post activation
in both control and high-fat fed groups in SWR mice. Levels
increased at 72 and 96 h in control compared to high-fat fed SWR
mice spleen lymphocytes. IL-1b levels were elevated in high-fat fed
Figure 3. Follistatin is increased in muscle of HFDIO-susceptible mice fed a high-fat diet. The molecular regulation of follistatin (FSTN)m R N Al e v e l s
was analyzed by real-time PCR. Follistatin mRNA levels in muscle from C57BL/6 (a) and SWR/J (c) and spleen from C57BL/6 (b) and SWR/J (d). Muscle and spleen
samples were taken at 3, 6, 9, and 12 wk on the dietary treatment. * demonstrates between dietary treatment differences at a given time, P,0.05.
doi:10.1371/journal.pone.0012928.g003
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levels in C57BL/6 control mice were undetectable. At 96 h, no
difference was detected between control and high-fat C57BL/6
mice. IL-1b levels in SWR spleen supernatants were undetectable,
with the exception of control sample at 96 h. IL-6 levels were
consistently detected in C57BL/6 spleen lymphocytes from both
treatment groups, but only detected at 48 h in both treatments in
SWR mice spleen cell supernatants (Fig. 6d). IL-6 levels were
elevated in control C57BL/6 mice at 96 h compared to high-fat
fed mice.
Granulocyte macrophage colony stimulating factor (GM-
CSF) levels were elevated in SWR mice compared to C57BL/6
at all time points (Fig. 7a). No difference was detected between
control and high-fat fed mice at 48 h in SWR mice, but at 72 h
GM-CSF levels were elevated in SWR high-fat fed mice spleen
lymphocyte supernatants compared to control. At 96 h, GM-
CSF levels were elevated in SWR control spleen lymphocytes
compared to high-fat SWR. Differences were not detected in
tumor necrosis factor-a (TNFa) levels between treatment groups
in SWR mice at 48 or 72 h, but levels were elevated at 96 h in
control spleen samples (Fig. 7b). In C57BL/6 mice, TNFa levels
were elevated at 72 h in high-fat fed mice compared to controls,
and no differences were detected at 48 or 96 h. Levels of IL-1A,
IL-10, and IL-12 were below detection limits of the assay
(12.0 pg/ml).
Differences in lymphocyte populations were detected
between susceptible versus resistant strains of mice
following flow cytometric analysis of splenic lymphocyte
populations
Measurement of inflammatory cytokine production following
global activation of splenic T cells from susceptible and resistant
mice fed either control or high-fat diets revealed distinct
differences, which suggests that the lymphocytic environment is
quite different both before and after the institution of dietary
treatment. Splenocytes harvested from identically housed groups
of mice were analyzed for differences in lymphocyte frequencies
both to investigate possible sources of these inflammatory
cytokines, and to determine potential downstream effects these
differential cytokine potentials may exact on lymphocyte popula-
tion dynamics. Frequencies of CD4
+, CD8
+, and CD19
+ cells were
determined as well as the frequency of cells expressing CD25 or
CD69, which would be indicative of recent activation, and CD44,
which is a cumulative measure of past activation (Fig. 8). No
significant differences in total CD4
+, CD8
+, or CD19
+ lymphocyte
populations were detected between C57BL/6 and SWR mice
regardless of dietary treatment (Fig. 9). However, within C57BL/6
mice the frequency of previously activated CD8
+ and CD4
+ T cells
(CD8
+/CD44
hi and CD4
+/CD44
hi) were elevated in high-fat fed
mice compared to controls (Fig. 9).
Figure 4. Precursor myostatin expression is higher in HFDIO-susceptible mice. Representative Western ligand blots demonstrating total
muscle (a) and spleen (b) myostatin prodomain immunoreactive peptides (MPIPs). In muscle tissue, MPIPs were detected at 37 and 50 kDa,
representing the prodomain of myostatin and the precursor protein, respectively. In spleen tissue, MPIPs were detected at 16 and 32 kDa,
representing processed prodomain peptides and potentially further processed peptides, respectively. a.) Representative muscle protein samples from
SWR/J and C57BL/J high-fat (HF) and control [7] fed mice. b.) Representative spleen protein samples. Lane 1: molecular weight marker, 2,3,5,7: C57BL/
6 spleen, 4,6: SWR spleen, 8: -control, SWR adipose tissue protein. c, d. Relative quantification of arbitrary densitometry values from C57BL/6 (B6) and
SWR mice fed control or high-fat diets for 12 weeks. No differences were detected at 9 or 12 wks for any MPIP or for muscle 37 kDa, spleen 16 kDa
MPIPs, data not shown. Differences marked with lines were considered significantly different at P,0.05.
doi:10.1371/journal.pone.0012928.g004
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C57BL/6 mice are highly susceptible to high-fat diet
induced obesity, while SWR mice are resistant
As anticipated, C57BL/6 mice are highly susceptible to high-fat
diet induced obesity, with a significant increase in weight seen as
early as three weeks on the diet. Following 12 wk on a high-fat
diet, C57BL/6 mice almost doubled their initial weight. Consistent
with these results, a similar increase in whole blood glucose levels
was detected in C57BL/6 mice on the high-fat diet. In addition,
glucose levels continue to rise in high-fat fed C57BL/6 mice as
time on the diet increases. In contrast, there were no differences
detected in weight or whole blood glucose levels in SWR mice over
the 12-week feeding trial. These data suggest that the SWR strain
of mice is resistant to the body weight and insulin challenges seen
in C57BL/6 mice on a high-fat diet and is consistent with previous
work [24,25].
This is the first report of differential MSTN regulation in a non-
muscle tissue, and specifically expression in isolated leukocytes
from a mammalian species (Fig. 2e). As expected, MSTN levels
were significantly different between strains in response to high-fat
diet intake. Most notable is the dramatic decrease in MSTN levels
in whole spleen tissue of SWR mice in response to a high-fat diet.
Overall levels of MSTN mRNA in control SWR spleen appear
lower than levels detected in C57BL/6 spleen tissue but were not
significantly lower (Fig. 10a), possibly due to the high variability
detected in C57BL/6 control spleen MSTN mRNA levels.
However, in SWR mice fed a high-fat diet MSTN mRNA levels
were consistently lower than levels observed in control SWR or
C57BL/6 mice, suggesting a different regulatory mechanism is
activated in response to high-fat diet intake in HFDIO-resistant
animals. A dramatic increase in spleen MSTN mRNA levels was
detected in C57BL/6 mice with 3 wk of high-fat diet intake and
no differences detected at other sampling times. These results are
intriguing as they are consistent with previous reports of MSTN
knockout mice being resistant to high-fat diet induced obesity
[26,27] as HFDIO-resistant mice in this study exhibit lowered
levels of MSTN expression. However, one difference is that our
study demonstrates a dramatic down-regulation of MSTN in
spleen tissue, with only an initial decrease in MSTN levels in
muscle tissue following 3 wk of high-fat diet intake. Guo and co-
workers demonstrated that removal of myostatin activity in
adipose tissue results in no differences to body composition,
weight gain, glucose or insulin sensitivity, and were not resistant to
HFDIO, suggesting that metabolic changes in skeletal muscle are
required for improved HFDIO-resistance and metabolic handling.
In muscle tissue, MSTN mRNA levels were elevated in C57BL/
6 in response to high-fat diet, as well as in SWR mice following 9
and 12 wk of high-fat diet intake. Interestingly, control levels of
MSTN were higher in muscle from SWR mice compared to
control C57BL/6 mice (Fig. 10b). It is possible that higher levels of
MSTN mRNA in younger SWR mice play an important role in
sensitizing them to metabolic shifts compared to C57BL/6 mice. It
is possible that timing of high-fat diet intake affects the animal’s
ability to handle the excess lipid. In older SWR mice, around 20
weeks of age (respective to the 12 wk sampling time), muscle
MSTN levels are reduced compared to C57BL/6 levels. Myostatin
has been shown to promote adipogenesis in vitro [28,29], and in
this study we demonstrate that in HFDIO-resistant mice increases
in lipid consumption initially decrease MSTN levels in muscle and
spleen tissue with more of an effect in spleen tissue. Taken together
with Guo and co-worker’s results demonstrating that removal of
MSTN activity in muscle is required for HFDIO resistance, we
suggest that MSTN might play a substantial role in metabolic shift
regulation that occurs in muscle cells during increased lipid intake
that results in either increased glucose uptake or increases
intramyocellular lipid accumulation, depending on resistance of
susceptibility. It is also likely that myostatin plays a significant role
in spleen tissue as well.
Different sized immunoreactive peptides were detected between
the two tissues, indicating potential tissue-specific processing of
MSTN. Results indicate that only strain has an effect on MSTN
protein levels and that dietary lipid intake does not have any effect
on MSTN protein processing. In C57BL/6 muscle tissue,
precursor MSTN (,50 kDa) expression levels were higher than
SWR mice with no effect of diet. In addition, processed MSTN
Figure 5. IL-4 levels are attenuated in HFDIO-resistant mice
when fed a high fat diet. Cytokine levels in ex vivo CD3
+/CD28
+
splenocytes from SWR and C57BL/6 (B6) mice at 48, 72, and 96 h after
activation. IL-4 (a), IL-2 (b), and IL-5 (c) levels were measured by cytokine
expression array. IL-4 and IL-5 levels were not detectable in C57BL/6
mice splenocytes in this assay. * P,0.05.
doi:10.1371/journal.pone.0012928.g005
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compared to SWR regardless of dietary treatment. These
differences in strain expression of MSTN could help explain
relative differences in sensitivity to glucose uptake and adipogen-
esis between the strains. However, the exact regulatory mecha-
nisms of MSTN action are not clear in vivo, and recent evidence
Figure 6. Pro-inflammatory cytokines are highest in HFDIO-susceptible mice. Cytokine expression from CD3
+/CD28
+ splenocytes from
C57BL/6 (B6) and SWR mice 48, 72, and 96 h after activation. IFNc (a), IL-17 (b), IL-1b (c), and IL-6 (d) protein levels. Different letters represent
significance at P,0.05.
doi:10.1371/journal.pone.0012928.g006
Figure 7. GM-CSF levels are higher in HFDIO-resistant mice. Granulocyte macrophage colony stimulating factor (GM-CSF) (a) and tumor
necrosis factor alpha (TNFa) (b) levels in activated CD3
+/CD28
+ splenocytes from C57BL/6 (B6) and SWR mice fed control or high-fat diets for 12
weeks. Different letters represent significance at P,0.05.
doi:10.1371/journal.pone.0012928.g007
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bound to components of the extracellular matrix [30,31,32]. This
level of activity control makes it difficult to interpret changes, or
lack there of, in steady-state expression of MSTN. However, to
further support the effect of high-fat diet intake on MSTN levels,
changes in follistatin mRNA levels were similar to MSTN levels with
consistent upregulation observed in C57BL/6 in response to lipid
intake. Collectively, these results indicate that MSTN plays a role
in HFDIO susceptibility and resistance and that tissue-specific
expression likely contributes to the role MSTN plays in metabolic
regulation.
Differences in IL-6 expression levels were not different between
dietary treatment groups in muscle or spleen tissue from C57BL/6
or SWR mice. This is interesting because IL-6 levels are known to
increase in circulation in obese and diabetic states [33,34], and IL-
6 is known to regulate glucose homeostasis [35,36]. The lack of
mRNA expression level differences between the strains of mice
suggests that either IL-6 production increases are a result of
adipose IL-6 production, translation rate increases, or post-
transcription modification changes. In addition, not all obese/
diabetic states are IL-6-dependent.
Cytokines are Responsive to Dietary Intake and Strain-
Specific Expression
Low-grade inflammation commonly observed with obesity is
thought to play an important role in increasing risk for metabolic
disorder [37,38]. Tissue inflammation following high-fat intake
results from the recruitment and activation of local macrophages
that release inflammatory cytokines that are thought to promote
insulin resistance locally [37,38,39]. Most attention has been paid
to adipose, skeletal muscle, and liver tissue in this regard. In this
project we focus on the changes in cytokine expression potential in
spleen tissue due to the dramatic differences observed in myostatin
expression between HFDIO-resistant and susceptible mice.
Cytokine expression data supports interactions between strain,
diet, and potential immune system regulation. IL-6 is thought to
play an important role in the inflammatory-related pathogenesis of
obesity. Interestingly, no difference was detected in IL-6 levels in
total spleen or muscle from either mouse strain. However, IL-6
protein expression by lymphocytes isolated from low-fat-fed
C57BL/6 mice was elevated following 96 h of activation by
CD3/CD28 stimulation, which results in activation of the total T
lymphocyte population. Interestingly, levels dropped below the
detection limit of the assay in SWR mice 72 and 96 h following
activation in both feeding groups, suggesting a strain-dependent
difference in potential activation response.
IL-4 is a cytokine (prototypically Th2) important for B cell
activation, antibody production, Th2 cell proliferation and
differentiation, as well as in macrophage fusion and myoblast
recruitment and fusion [40,41]. IL-4 is also important in down-
regulating the production of IFNc, a key proinflammatory
cytokine. IL-4 expression was consistently lower in high-fat fed
SWR activated lymphocytes compared to the control fed SWR
group at all sampling times, while expression was undetectable in
C57BL/6 mice at all time-points tested, regardless of diet.
Interestingly, a recent report demonstrated that central IL-4
administration in conjunction with a high-fat diet led to
hypothalamic inflammation and HFDIO [42], indicating a pro-
inflammatory response to IL-4. It is likely that IL-4 functions as
pro- or anti-inflammatory in response to the cellular and
physiological environment.
IL-2 expressionpotential was similar to that of IL-4, as IL-2levels
decreased in high-fat diet fed SWR mice compared to control diet
fed mice at all time points. IL-2 is a cytokine known to maintain T
regulatory cells for self/non-self recognition during infection, as well
as stimulate growth, differentiation, and survival of T cells. IL-5,
important in stimulating B cell growth, levels were elevated in SWR
mice compared to C57BL/6 mice regardless of diet. In contrast to
IL-4, IL-5 expression was higher in high-fat fed SWR mice
compared to control fed animals. Together the data reported here
indicate that cytokine expression potential of splenoctyes may play
particularly important roles in the ability of SWR mice to handle an
increased lipid load without increasing weight or lipid deposition or
any apparent pro-inflammatory response.
In contrast to the expression of anti-inflammatory cytokines in
response to high-fat diet in the obesity-resistant SWR animal,
obesity-prone C57BL/6 animals presented with evidence of an
increased inflammatory response resulting from the high-fat diet.
When compared to SWR mice, IFNc levels were consistently
higher in activated T lymphocytes from C57BL/6 mice spleen
regardless of dietary treatment, with the exception of the high-fat
fed SWR group at 48 h after activation. IFNc is a hallmark Th1-
type cytokine that, among its many roles, stimulates inflammation.
Macrophages accumulate in adipose tissue during obesity [43] and
IFNc produced by these macrophages was recently shown to
regulate fat inflammation during obesity [44]. In addition,
evidence suggests that the increase in systemic TNF-a in obesity
is derived from these adipose macrophages, which suggests that
this increase in infiltrated macrophages might represent the cause
or consequence of the low-grade inflammation observed in obesity
[45,46,47,48]. The increased potential of IFNc production by
C57BL/6 activated splenic lymphocytes and potentially macro-
phages, presented here is consistent to the previously described
systemic inflammation regulation.
The most notable differences reported are the strain difference
in response to high-fat diet intake on IL-17 and IL-1b levels, both
cytokines that, along with IFNc, can drive the inflammatory
response. In C57BL/6 mice, high-fat diet increased both cytokines
expression level potential with a time-dependant increase in IL-1b
levels. Levels of IL-17 and IL-1b were not detectable in high-fat
fed SWR mice, and only detectable in control mice over time. The
increased IL-1b, IL-17, and IFNc potential levels detected in
C57BL/6 mice fed a high-fat diet were not correlated (P=0.85),
however a clear strain difference is detected. Thus, the splenic
environment of HFDIO-susceptible (C57BL/6) mice could
contribute to increased systemic inflammation seen in respond to
a high-fat diet, compared to the more protective anti-inflamma-
tory response that is possible in SWR mice.
Lymphocyte populations present in the spleens of SWR and
C57BL/6 mice in both dietary treatment groups were similar with
respect to CD4
+ and CD8
+ T cell groups, but higher frequencies
of both previously activated CD4
+ and CD8
+ cells (CD44
hi) were
detected in C57BL/6 mice fed a high-fat diet. Interestingly,
CD8
+/CD44
hi T cells have previously been identified as a potent
source of IFN-c [49,50]. The fact that C57BL/6 mice have a
greater frequency of these cells compared to SWR mice suggests
that they may be a potential source for the increased IFN-c
detected in the cytokine analysis.
Figure 8. T cell population frequency percentages were not different between strains. Splenocytes from identically housed C57BL/6 and
SWR/J mice fed control or high-fat diet were isolated and cell frequencies were measured by flow cytometry. A) Total lymphocyte frequencies by
strain and diet. B) Frequencies of CD4
+, CD8
+, CD4
+/CD44
hi, CD8
+/CD44
hi, and CD19 cells were determined.
doi:10.1371/journal.pone.0012928.g008
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+ and CD8
+ T cell populations observed in HFDIO-susceptible mice. To
address strain- or diet-specific shifts in lymphocyte populations, an evaluation of spleen cell frequencies of CD4
+ (a) and CD8
+ (b) T cells, CD19
+ B cells
(e) was conducted in naive C57BL/6 (B6) and SWR/J (SWR) mice fed control or high-fat diets. Cell populations were also stained for previously
activation marker CD44
hi, CD4/CD44
hi+ (c) and CD8/CD44
hi+ (d). Data are presented as total positive lymphocyte numbers/spleen. The total number
of cells counted was not significantly different between strains or dietary treatment. * represents differences between pairwise groups (P,0.05, n=4).
doi:10.1371/journal.pone.0012928.g009
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insulin resistance [37,38]. Data presented here suggested a genetic
link between diet, myostatin expression, and potential for
generating a proinflammatory response. Consistent with previous
reports of obesity-prone C57BL/6 mice responding to a high-fat
diet with the induction of a proinflammatory response [37,38], this
work demonstrates increased spleen production potential of IFNc,
IL1b, and IL-17. In contrast, obesity-resistant SWR mice
exhibited an increased spleen potential for lymphocytes to produce
greater levels of IL-4 and depressed potential for production of
proinflammatory cytokines.
The results of this study clearly show an interesting link between
susceptibility to high-fat diet induced obesity and myostatin
expression. Myostatin has been shown to regulate adipogenesis
and cell proliferation [29,51] and be regulated by stress [52,53,54].
It is clear that several factors confound the predisposition to
HFDIO, however it is apparent that myostatin plays a role in
regulating cell cycle regulation and metabolism and might be
acting as a sort of regulatory switch for metabolic shifts in a tissue-
specific manner. In HFDIO-resistant mice, myostatin levels are
consistently lower in spleen tissue than in susceptible mice. This
evidence provides further support that myostatin and its activity
are potential therapeutic targets for metabolic regulation. It is
possible that myostatin also serves as a modulator for innate
immune system regulation involved in inflammation progression
as dynamic changes were detected in splenocytes following high-
fat dietary intake. Further investigations are needed to empirically
identify regulatory interactions between metabolic- and inflam-
matory-regulating pathways to better understand the propensity
for diabesity and to provide opportunities for prevention.
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